Gene therapy in Parkinson’s disease: Targeting the endplasmic reticulum proteostasis network

Neural Regeneration Research

Volumn 10, Issue 7, 2015, Pages 1053-1054

  Castillo, Valentina ^a   Mercado, Gabriela ^a   Hetz, Claudio ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE; GLUTAMATE DECARBOXYLASE; LENTIVIRUS VECTOR; LEVODOPA; TRANSCRIPTION FACTOR; TYROSINE 3 MONOOXYGENASE;

ADENO ASSOCIATED VIRUS; BRAIN ELECTROPHYSIOLOGY; CLINICAL TRIAL (TOPIC); ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENZYME REPLACEMENT; GENE TARGETING; GENE THERAPY; HUMAN; IMMUNOGENICITY; MUTAGENESIS; NERVE DEGENERATION; NEUROPROTECTION; NOTE; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; SUBSTANTIA NIGRA PARS COMPACTA; SUBTHALAMIC NUCLEUS; UNFOLDED PROTEIN RESPONSE;

EID: 84938262536     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.160077     Document Type: Note

References (10)

1. Bartus RT, Weinberg MS, Samulski RJ (2014) Parkinson's disease gene therapy: success by design meets failure by efficacy. Mol Ther 22:487-497.
2. Colla E, Coune P, Liu Y, Pletnikova O, Troncoso JC, Iwatsubo T, Schneider BL, Lee MK (2012) Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo. J Neurosci 32:3306-3320.
3. Coune PG, Schneider BL, Aebischer P (2012) Parkinson's disease: gene therapies. Cold Spring Harb Perspect Med 2:a009431.
4. Coune PG, Bensadoun JC, Aebischer P, Schneider BL (2011) Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease. J Parkinsons Dis 1:373-387.
5. Gorbatyuk MS, Shabashvili A, Chen W, Meyers C, Sullivan LF, Salganik M, Lin JH, Lewin AS, Muzyczka N, Gorbatyuk OS (2012) Glucose regulated protein 78 diminishes alpha-synuclein neurotoxicity in a rat model of Parkinson disease. Mol Ther 20:1327-1337.
6. Hetz C, Mollereau B (2014) Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci 15:233-249.
7. Hetz C, Chevet E, Harding HP (2013) Targeting the unfolded protein response in disease. Nat Rev Drug Discov 12:703-719.
8. Mercado G, Valdes P, Hetz C (2013) An ERcentric view of Parkinson's disease. Trends Mol Med 19:165-175.
9. Sado M, Yamasaki Y, Iwanaga T, Onaka Y, Ibuki T, Nishihara S, Mizuguchi H, Momota H, Kishibuchi R, Hashimoto T, Wada D, Kitagawa H, Watanabe TK (2009) Protective effect against Parkinson's disease-related insults through the activation of XBP1. Brain Res 1257:16-24.
10. Valdes P, Mercado G, Vidal RL, Molina C, Parsons G, Court FA, Martinez A, Galleguillos D, Armentano D, Schneider BL, Hetz C (2014) Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1. Proc Natl Acad Sci U S A 111:6804-6809.